课题基金 / 基金详情

Fetal vascular ultrasound assessment to identify growth restriction and reduce stillbirth

Fetal vascular ultrasound assessment to identify growth restriction and reduce stillbirth
胎儿血管超声评估以识别生长受限并减少死产
批准号:
2606493
负责人:
金额:
$0.0万
依托单位:
依托单位国家:
英国
项目类别:
Studentship
财政年份:
2021
资助国家:
英国
项目状态:
未结题
起止时间:
2021 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Aim of the PhD Project:Develop a methodology which will enable fetal aortic elastic properties to be calculated from an ultrasound scan;Develop new ultrasound protocols and signal and image processing techniques for both current clinical imaging systems and state-of-the-art ultrasound imaging;Investigate whether aortic elasticity measured by this methodology differentiates growth-restricted from normal fetuses.Project description:There are over 3,000 stillbirths per year in the UK, many of which are associated with fetal growth restriction (FGR). Stillbirth affects about 1 in 200 pregnancies and is the leading cause of perinatal death. In 2016, the Lancet's "Ending Preventable Stillbirth Series" indicated that stillbirth rates in England and Wales are the highest in Western Europe and have changed little in the past 20 years.1,2 A recent UK study identified FGR, defined as a customised birthweight below the 10th percentile, as the single largest contributor to stillbirth rates, being responsible for about 43% of stillbirths.3One of the most promising approaches to reduce stillbirths is early diagnosis of FGR. It has been shown that the high mortality rates of FGR are mainly due to lack of recognition of the condition rather than inability to manage it.4 Preventive strategies mostly focus on altering socio-economic parameters, such as improved access to care, or improving maternal wellbeing prior to pregnancy, such as reduced maternal obesity rates.1 However, these strategies are difficult to implement in the mobile, older and more obese pregnant populations of current Western societies. Therefore, a method to accurately screen for FGR to diagnose it early is required.The main screening tool for FGR during pregnancy is fetal ultrasound (US) scanning, which can be used to measure fetal biometry (dimensions) from which fetal weight can be estimated, and fetal blood flow from which fetal adaptation to hypoxia can be assessed. However, despite these measurements, the sensitivity in detecting FGR remains <40%.5 Therefore, a more sensitive ultrasonographic marker is needed - compared to the traditional fetal biometry and blood flow Doppler examination - to identify those fetuses in the third-trimester scan who are at risk of FGR in the next few weeks.Assessment of fetal vasculature is emerging as a novel area of research with potential to provide information about fetal cardiovascular adaptations in response to maternal stimuli at a much earlier stage than can be detected by blood flow Doppler examinations in the uterine, middle cerebral, and umbilical arteries. It is now possible to assess fetal aortic properties using advanced US-based techniques, which may have utility in FGR screening. Data suggest that growth restricted fetuses have increased aortic stiffness,6,7 however to date there is no methodology which can be used in clinical practice to assess vascular elasticity during pregnancy.In this study, we aim to develop advanced US and pulse wave analysis techniques to estimate fetal vascular properties. This will include investigating the use of raw radio-frequency (RF) US data, as well as state-of-the-art ultrafast US imaging8, providing higher temporal resolution across the full field-of-view. We will assess whether aortic elasticity measured by these new techniques differentiates growth-restricted from normal fetuses. If our development is successful, this will provide a novel way to improve detection of FGR and reduce stillbirth rates. It is hoped that the methodology could be implemented in US scanners through our collaboration with Canon Medical Systems.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
环境抗雄激素干预AR/TGFB1I1致尿道下裂血管内皮细胞发育异常的机制及其“预警信号”在早期诊断中的价值
  • 批准号:
    82371605
  • 项目类别:
    面上项目
  • 资助金额:
    46.00万元
  • 批准年份:
    2023
  • 负责人:
    蒋君涛
  • 依托单位:
尾加压素II介导血管外膜氧化应激促进血管重构的作用研究
  • 批准号:
    81141003
  • 项目类别:
    专项基金项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2011
  • 负责人:
    丁文惠
  • 依托单位:
核素靶向示踪肿瘤新生血管作用位点研究
  • 批准号:
    81071183
  • 项目类别:
    面上项目
  • 资助金额:
    32.0万元
  • 批准年份:
    2010
  • 负责人:
    王荣福
  • 依托单位:
硫化氢通过核转录因子-kB信号途径调节高血压大鼠血管平滑肌细胞增殖的研究
  • 批准号:
    81070212
  • 项目类别:
    面上项目
  • 资助金额:
    33.0万元
  • 批准年份:
    2010
  • 负责人:
    金红芳
  • 依托单位: